Cyhoeddiadau
2020
- Michael, D. R.et al. 2020. A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being. Scientific Reports 10(1), pp. -., article number: 4183. (10.1038/s41598-020-60991-7)
2019
- Michael, D.et al. 2019. In vitro neuroprotective activities of two distinct probiotic consortia. Beneficial Microbes 10(4), pp. 437-447. (10.3920/BM2018.0105)
2018
- Boshra, H.et al. 2018. Absence of CD59 in guinea pigs: Analysis of the Cavia porcellus genome suggests the evolution of a CD59 pseudogene. Journal of Immunology 200(1), pp. 327-335. (10.4049/jimmunol.1701238)
2017
- Michael, D. R.et al. 2017. The anti-cholesterolaemic effect of a consortium of probiotics: an acute study in C57BL/6J mice. Scientific Reports 7, article number: 2883. (10.1038/s41598-017-02889-5)
- Bergfeld, A.et al. 2017. Direct binding of the pH-regulated protein 1 (Pra1) from Candida albicans inhibits cytokine secretion by mouse CD4+ T cells. Frontiers in Microbiology 8 (10.3389/fmicb.2017.00844)
- Granados-Durán, P.et al. 2017. Microbial neuraminidase induces a moderate and transient myelin vacuolation independent of complement system activation. Frontiers in Neurology 8, article number: 78. (10.3389/fneur.2017.00078)
2016
- Granados-Duran, P.et al. 2016. Complement system activation contributes to the ependymal damage induced by microbial neuraminidase. Journal of Neuroinflammation 13(115) (10.1186/s12974-016-0576-9)
- Towner, L. D.et al. 2016. Complement membrane attack and tumorigenesis: a systems biology approach. Journal of Biological Chemistry 291(29), pp. 14927-14938. (10.1074/jbc.M115.708446)
- Bloom, A. C.et al. 2016. Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice. Bone 84, pp. 253-261. (10.1016/j.bone.2015.12.014)
- Triantafilou, M.et al. 2016. Complementing the inflammasome. Immunology 147(2), pp. 152-164. (10.1111/imm.12556)
2015
- McCully, M. L.et al. 2015. Skin metabolites define a new paradigm in the localization of skin tropic memory T cells. Journal of Immunology 195(1), pp. 96-104. (10.4049/jimmunol.1402961)
- Ramaglia, V.et al. 2015. Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Clinical & Experimental Immunology 180(3), pp. 432-441. (10.1111/cei.12595)
- Davies, T. S.et al. 2015. Interferon gamma signalling in atherosclerosis: pro-atherogenic actions and therapeutic approaches. Cardiology 131, pp. 292-292.
2014
- Towner, L., Hughes, T. and Morgan, B. P. 2014. Exploring the effects of non-lethal complement membrane attack on CT26 Colon Carcinoma cells using network analysis of differentially expressed genes. Molecular Immunology 61(2), pp. 245-246.
- Davies, T. S.et al. 2014. Pro- therogenic actions of interferon-gamma on macrophages in atherosclerosis. Cardiology 128(S1), pp. 278-278. (10.1159/000365062)
- Steiner, T.et al. 2014. Protective role for properdin in progression of experimental murine atherosclerosis. PLoS ONE 9(3), article number: e92404. (10.1371/journal.pone.0092404)
2013
- Triantafilou, K.et al. 2013. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. Journal of Cell Science 126(13), pp. 2903-2913. (10.1242/jcs.124388)
- Laudisi, F.et al. 2013. Cutting edge: The NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. The Journal of Immunology 191(3), pp. 1006-1010. (10.4049/jimmunol.1300489)
- Killick, R.et al. 2013. Corrigendum to “Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH” [Neurosci. Lett. 533 (2013) 96–99] [Corrigendum]. Neuroscience Letters 545, pp. 144-144. (10.1016/j.neulet.2013.05.004)
- Killick, R.et al. 2013. Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. Neuroscience Letters 533, pp. 96-99. (10.1016/j.neulet.2012.11.008)
- Kandasamy, M.et al. 2013. Complement mediated signaling on pulmonary CD103+ dendritic cells is critical for their migratory function in response to influenza infection. PLoS Pathogens 9(1), article number: e1003115. (10.1371/journal.ppat.1003115)
2012
- Ramaglia, V.et al. 2012. C3-dependent mechanism of microglial priming relevant to multiple sclerosis. Proceedings of the National Academy of Sciences 109(3), pp. 965-970. (10.1073/pnas.1111924109)
2011
- Lewis, R. D.et al. 2011. CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism. American Journal of Pathology 179(4), pp. 1601-1607. (10.1016/j.ajpath.2011.06.015)
- Lueck, K.et al. 2011. Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. Eye 25(8), pp. 1074-1082. (10.1038/eye.2011.109)
2010
- Gray, L. C., Hughes, T. R. and Van Den Berg, C. W. 2010. Binding of human antigen R (HuR) to an AU-rich element (ARE) in the 3' untranslated region (3' UTR) reduces the expression of decay accelerating factor (DAF). Molecular Immunology 47(16), pp. 2545-2551. (10.1016/j.molimm.2010.07.002)
- Lewis, R. D.et al. 2010. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. Molecular Immunology 47(5), pp. 1098-1105. (10.1016/j.molimm.2009.10.035)
- Copland, D. A.et al. 2010. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clinical and Experimental Immunology 159(3), pp. 303-314. (10.1111/j.1365-2249.2009.04070.x)
2009
- Hughes, T. R.et al. 2009. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59. Molecular Immunology 46(7), pp. 1561-1567. (10.1016/j.molimm.2009.01.003)
- Ruseva, M. M.et al. 2009. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. Molecular Immunology 46(5), pp. 803-811. (10.1016/j.molimm.2008.09.003)
2008
- Donev, R. M.et al. 2008. Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma [RETRACTED]. Cancer Research 68(14), pp. 5979-5987. (10.1158/0008-5472.CAN-07-6828)
2007
- Sivasankar, B.et al. 2007. CD59a deficient mice display reduced B cell activity and antibody production in response to T-dependent antigens. Molecular Immunology 44(11), pp. 2978-2987. (10.1016/j.molimm.2006.12.025)
2006
- Donev, R. M.et al. 2006. p53 regulates cellular resistance to complement lysis through enhanced expression of CD59 [RETRACTED]. Cancer Research 66(4), pp. 2451-8. (10.1158/0008-5472.CAN-05-3191)
- Irvine, S. A.et al. 2006. Lipoprotein lipase is expressed by glomerular mesangial cells. The International Journal of Biochemistry & Cell Biology 38(1), pp. 12-16. (10.1016/j.biocel.2005.07.008)
2003
- Mead, J. R.et al. 2003. Interferon-γ stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2: A Potentially novel pathway for interferon-γ-mediated inhibition of gene transcription. Journal of Biological Chemistry, pp. 17741-17751. (10.1074/jbc.M301602200)
2002
- Hughes, T. R.et al. 2002. A novel role of Sp1 and Sp3 in the interferon- -mediated suppression of macrophage lipoprotein lipase gene transcription. Journal of Biological Chemistry 277(13), pp. 11097-11106. (10.1074/jbc.M106774200)
2001
- Kockar, F. T.et al. 2001. Analysis of the Xenopus laevis CCAAT-enhancer binding protein α gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1. Nucleic Acids Research 29(2), pp. 362-372. (10.1093/nar/29.2.362)
2000
- Granger, R. L., Hughes, T. R. and Ramji, D. P. 2000. Gene, stimulus and cell-type specific regulation of activator protein-1 in mesangial cells by lipopolysaccharide and cytokines. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1492(1), pp. 100-107. (10.1016/S0167-4781(00)00089-0)
- Granger, R. L., Hughes, T. R. and Ramji, D. P. 2000. Stimulus- and cell-type-specific regulation of CCAAT-enhancer binding protein isoforms in glomerular mesangial cells by lipopolysaccharide and cytokines. Biochimica et Biophysica Acta - Molecular Basis of Disease 1501(2-3), pp. 171-179. (10.1016/S0925-4439(00)00016-8)